| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Seres Therapeutics, Inc. (MCRB) have been net sellers, shedding 490 shares worth roughly $2K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 12.5K | $24.5K | - | |
| Other | 8.7K | $17.0K | - | |
| Other | 8.6K | $16.8K | - | |
| Other | 8.1K | $15.9K | - | |
| Other | 8.0K | $15.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2018 | Michele Trucksis | See Remarks | Sale+OE | 2,607 | $11.02 | $28,729.14 | -34.8% | |
| Jan 26, 2018 | Thomas DesRosier69 | See Remarks | Sale+OE | 3,475 | $11.02 | $38,294.50 | -34.8% | |
| Jan 26, 2018 | David N Cook | See Remarks | Sale+OE | 1,738 | $11.02 | $19,152.76 | -1.2% | |
| Jan 26, 2018 | Eric D. Shaff69 | See Remarks | Sale+OE | 2,780 | $11.02 | $30,635.60 | -34.8% | |
| Jan 26, 2018 | John G. Aunins | See Remarks | Sale+OE | 1,738 | $11.02 | $19,152.76 | -0.9% | |
| Dec 19, 2017 | John G. Aunins | Chief Technology Officer & EVP | Sale+OE | 1,623 | $10.14 | $16,457.22 | -2.7% | |
| Aug 29, 2016 | John G. Aunins | Chief Technology Officer & EVP | Sell | 9,390 | $10.87 | $102,069.30 | -4.7% | |
| Jul 28, 2016 | Michele Trucksis | Chief Medical Officer and EVP | Sale+OE | 4,156 | $35.18 | $146,207.25 | - | |
| Jul 27, 2016 | John G. Aunins | Chief Technology Officer & EVP | Sell | 9,250 | $35.00 | $323,750.00 | -4.4% | |
| Jul 27, 2016 | Roger Pomerantz | President and CEO | Sale+OE | 20,000 | $35.00 | $700,000.00 | -9.8% |